pharmaphorum7d
Lilly's Olumiant okayed in alopecia, with Pfizer, Concert in hot pursuit
Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug ... alopecia, although that is likely to diminish now that an FDA-approved option is available. The new ...
Hosted on MSN1mon
Man with alopecia says he is being denied life changing drug – despite NHS approval
A man suffering alopecia says he is being denied a groundbreaking new drug – despite it being approved. The daily pill, called ritlecitinib or Litfulo, was green-lit for prescription on the NHS ...
Pharmabiz1d
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...
WebMD1mon
How Olumiant Works for Alopecia
New treatments like Olumiant offer hope for some people. This FDA-approved medicine works in unique ways to help improve hair regrowth. Olumiant provides people with alopecia areata another option ...
Too Old to Operate6d
FDA Approved Dermatologic Therapies in 2024
The following is a summary of “A year in review: new treatments and expanded indications in dermatology in 2024,” published in the January 2025 issue of Dermatology by McGrath et al. In 2024, ...
HCW Biologics receives clearance of IND from FDA for HCW9302
HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...
BGR6d
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
USA Today6d
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
The American Journal of Managed Care7d
Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA
Suzetrigine's approval highlights the ongoing need for effective non-opioid pain management solutions. Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years ...
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...
BioSpace6d
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Medscape4d
Acute Diffuse and Total Alopecia: A New Subtype Of Alopecia Areata With A Favorable Prognosis. F1000: "Changes Clinical Practice"
Changes Clinical Practice: A biopsy and hair root examination should be performed in cases of sudden-onset diffuse alopecia. This article is interesting because of the illustration that acute ...